PharmGKB summary

This publication has 64 references indexed in Scilit:

• Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
  Clinical Pharmacology & Therapeutics, 2011
• Vitamins C and E: Beneficial effects from a mechanistic perspective
  Free Radical Biology and Medicine, 2011
• Genome-wide association study identifies common variants associated with circulating vitamin E levels
  Human Molecular Genetics, 2011
• Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
  JAMA, 2011
• Genetic and nongenetic factors associated with warfarin doserequirements in Egyptian patients
  Pharmacogenetics and Genomics, 2011
• 20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension
  Journal of Cardiovascular Pharmacology, 2010
• CYP4F2rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
  British Journal of Clinical Pharmacology, 2010
• Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
  New England Journal of Medicine, 2009
• Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
  Contemporary Clinical Trials, 2009
• Expression of CYP4F2 in human liver and kidney: Assessment using targeted peptide antibodies
  Archives of Biochemistry and Biophysics, 2008